Form 4: TransMedics Group CEO Waleed Hassanein Acquires Shares and Stock Options
SEC Form 4 Filing
TransMedics Group CEO Waleed Hassanein reports acquisition of restricted stock units and stock options.
Summary
- On February 23, 2024, Waleed H. Hassanein, the President and CEO of TransMedics Group, Inc., acquired 36,755 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of TransMedics Group's common stock.
- Following this transaction, Hassanein directly owns 543,446 shares of common stock.
- Hassanein also acquired options to purchase 56,645 shares of common stock at an exercise price of $83.14.
- The options vest monthly at a rate of 2.0833% starting February 23, 2024, and will be fully vested on February 23, 2028, contingent upon continued service.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The CEO's increased stake could be seen as slightly positive, but it's not a major event.
Positives
- The CEO's acquisition of shares and options could be interpreted as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- Shareholders may view the CEO's increased ownership as a positive sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of transaction: Acquisition of RSUs and stock options. |
| 02/23/2028 | Date the stock options are fully vested. |
| 02/27/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.